A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma Patients
Clinical trial NCT02963389 · COMPLETED
Trial details
- NCT number
- NCT02963389
- Sponsor
- Dong-A ST Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-04
- Primary completion
- 2018-11-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.